Skip to Content

Merck KGaA Annual General Meeting: Shareholders Approve Dividend of ? 1.00 per Share

Frankfurt am Main/Darmstadt, April 9, 2010 – Merck KGaA shareholders approved a dividend of € 1.00 per share for 2009 at the company’s Annual General Meeting held today at the Jahrhunderthalle in Frankfurt. This corresponds to a total payout of about € 217 million (based on the theoretical number of shares). In addition, the Annual General Meeting approved the actions of the Executive Board and the Supervisory Board for fiscal 2009 and approved all resolutions. 

In his speech, the Chairman of the Executive Board, Dr. Karl-Ludwig Kley, reviewed 2009 and gave shareholders an outlook for the future. In addition, Kley commented on the recently announced acquisition of Millipore, looked at the German health-care policies and described Merck’s special business model: “Our business model has once again proven its worth. First of all, we are adhering to our strategic direction: We are a pharmaceutical and chemical company. We operate in a number of businesses with different risk profiles. Balancing risk is essential for us. Secondly, in our Pharmaceuticals and Chemicals businesses, we will continue to focus on specialty businesses in the future. Competing on price alone and operating in commodity markets is not what we do. And thirdly, we will continue to invest significantly in research and development. That’s because new products and solutions are the only way we can help our customers and patients to live a better, and in some cases also a longer, life. Innovation remains our elixir of life.”
About 1,200 shareholders took part in the Annual General Meeting. A total of 37,624,121 shares were represented in the voting on the resolutions. This corresponds to 58.2% of the share capital of approximately 64.6 million total shares.

The full version of Dr. Kley’s speech is available online at:

All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to to register online, change your selection or discontinue this service.

Merck is a global pharmaceutical and chemical company with total revenues of € 7.7 billion in 2009, a history that began in 1668, and a future shaped by approximately 33,000 employees in 61 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

Posted: April 2010